BED-PSMA-301: PET for Prostate Cancer - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn more about the safety and performance of a radioactive tracer agent called rhPSMA-7.3 (18F) in Positron Emission Tomography (PET) imaging for prostate cancer.
Who Can Participate in the Study?
Men, 18+ who:
- Have intermediate-risk prostate cancer
- Are candidates for radical prostatectomy with pelvic lymph node dissection
- Do not have any other health conditions that may risk your ability to participate in the study
What is Involved?
If you choose to join this study, you will:
-Complete 3 study visits
-Have blood tests and physical exams
-Have the study agent (rhPSMA-7.3) given
-Have a research PET imaging scan
-Complete follow-up evaluations